Replies to post #621804 on NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

"Joshua Mitts published his analysis of 1,720 pseudonymous posts attacking publicly listed stocks on financial website Seeking Alpha between 2010 and 2017. His study found such posts were preceded by unusual and suspicious trading through stock options, in a process he called "short and distort".

Prior to 2018, the battle between U.S. companies and their detractors focused largely on the merits of short sellers and the veracity of their claims. Mitts' work gave companies new ammunition: they could use data to point to potentially manipulative trading tricks and allege fraud."

https://www.law.berkeley.edu/wp-content/uploads/2019/05/Mitts-Short-and-Distort-_111.pdf

It's the usual "run of the mill" 101 tutorial in a short and distort scam. Seeking Alpha is a cesspool like Motley Fool for fudders writing short and distort articles.

The author has zero knowledge about whats happening, or he has a financial incentive for showing he has zero knowledge about whats happening.

Currently one actually only needs to follow one elementary development.

1) That the UK announced the Pathway to a Cure report February 28th
2) That british politicians highest priority recommendation are

a) Explore how the MHRA, HTA, and NICE can cooperate better to enable new treatments to be made available in the UK, such as immune vaccination, and immune cell therapy which use a patient’s own specific antigens and dendritic
cells respectively

b) Where possible, external controls such as previous trials data to replace placebos for brain tumour patients

Boiling it all down to ... that the UK are prepared to both approval and reimburse the treatment with DCvax-L.

Any other speculations about trial design, financial situation, Linda Powers Toucan ownership, Advent lease, Huawei ... or whatever bullshit has been concocted by fudders ... are to be flushed down the drain.

By all means follow that twats advice.